Found 11 matching trials
Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection PHASE2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Centre ...
Show More Location
S N Medical College
Learn More & Join Trial
Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults PHASE1 Successful control of the HIV epidemic will require a safe and effective va...
Show More Location
Brigham and Women's Hosp. Novel Adenoviral Vector Prophylactic HIV Vaccine Non-Network CRS
Learn More & Join Trial
Study of Gam-COVID-Vac in Adolescents PHASE2 Double-blind, placebo-controlled study with open dose selection period for ...
Show More Location
Children's City Clinical Hospital named after Z.A. Bashlyaeva of the Moscow Department of Health
Learn More & Join Trial
Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray PHASE1 Randomized, double-blind, placebo-controlled trial to evaluate safety and i...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 PHASE3 Randomized, double-blind (blinded for the trial subject and the study physi...
Show More Location
ARCHIMED V Clinic of new medical technologies limited liability company
Learn More & Join Trial
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus PHASE3 Randomized, double-blind (blinded for the trial subject and the study physi...
Show More Location
Health Institution "14th Central Regional Polyclinic of the Partisan district of Minsk"
Learn More & Join Trial
Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela PHASE3 Randomized, double-blind, placebo controlled clinical trial of immunogenici...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults PHASE1 Investigators will examine the safety of and immune responses to two vaccin...
Show More Learn More & Join Trial
Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector PHASE1 This study will evaluate the safety and preliminary immune response to reco...
Show More Learn More & Join Trial
Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults PHASE1 The purpose of this study is to evaluate the immune response to the Vaccine...
Show More Learn More & Join Trial